HYBRID CELL-BASED THERAPY UNIT Russian patent published in 2010 - IPC A61F2/02 

FIELD: medicine.

SUBSTANCE: unit comprises a porous external wall for vascularisation, an internal space for the storage of an implanted biological material including a selected tissue/cell product, and for the vascular tissue enrichment of the implanted biological material from the external porous wall; a liquid collector for the immunosuppressive and/or growth factor infusion in the specified space. The collector comprises a longitudinal microperforated tube. A pump or medium container is connected to the collector. A method of biological material implantation involves the implantation of said unit, enabled fibrogenesis through the porous external wall into the internal space, arrangement of the biological material including the chosen tissue/cell product in the specified internal space, immunosuppressive and/or growth factor medium infusion in the internal space.

EFFECT: eliminated prolonged systemic immunosuppression of cell graft recipients.

19 cl, 3 dwg